BioSpace News Archive

Press Releases

Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial

April 1, 2025
·
6 min read
Press Releases

RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

April 1, 2025
·
17 min read
Press Releases

MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders

April 1, 2025
·
4 min read
Press Releases

Model Medicines Advances AI-Driven Drug Safety Prediction with AmesNet™, Achieving Unprecedented Accuracy and Sensitivity in Mutagenicity Testing

April 1, 2025
·
1 min read
Press Releases

Cytonics Announces that Last Patient Completes Last Visit in First-in-Human Phase 1 Clinical Trial for CYT-108 as a Treatment for Osteoarthritis

April 1, 2025
·
6 min read
Press Releases

Life Spine, Inc. Appoints Richard Mueller as President & Chief Executive Officer

April 1, 2025
·
1 min read
Press Releases

Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24

April 1, 2025
·
3 min read
Press Releases

Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation

April 1, 2025
·
7 min read
Press Releases

Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (MDD) with and without Excessive Daytime Sleepiness (EDS)

April 1, 2025
·
7 min read
Press Releases

Adams Clinical Site Network Announces Promotion of Dr. Stephanie Rutrick to Chief Medical Officer

April 1, 2025
·
2 min read